Your browser doesn't support javascript.
loading
International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives.
Marthin, June K; Lucas, Jane S; Boon, Mieke; Casaulta, Carmen; Crowley, Suzanne; Destouches, Damien M S; Eber, Ernst; Escribano, Amparo; Haarman, Eric; Hogg, Claire; Maitre, Bernard; Marsh, Gemma; Martinu, Vendula; Moreno-Galdó, Antonio; Mussaffi, Huda; Omran, Heymut; Pohunek, Petr; Rindlisbacher, Bernhard; Robinson, Phil; Snijders, Deborah; Walker, Woolf T; Yiallouros, Panayiotis; Johansen, Helle Krogh; Nielsen, Kim G.
Afiliação
  • Marthin JK; Danish PCD Centre Copenhagen, Paediatric Pulmonary Service, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Lucas JS; Primary Ciliary Dyskinesia Centre, NIHR Respiratory Biomedical Research Centre, Clinical and Experimental Science, University of Southampton, Southampton, UK.
  • Boon M; Dept of Paediatrics, University Hospital Gasthuisberg, Leuven, Belgium.
  • Casaulta C; Division of Paediatric Respiratory Medicine, University Children's Hospital, Bern, Switzerland.
  • Crowley S; Paediatric Dept of Allergy and Lung Diseases, Oslo University Hospital, Oslo, Norway.
  • Destouches DMS; Association des Patients Ayant une Dyskinésie Ciliaire Primitive, Limeil-Brevannes, France.
  • Eber E; Patient representative.
  • Escribano A; Division of Paediatric Pulmonology and Allergology, Dept of Paediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
  • Haarman E; Pediatric Pulmonology Unit, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain.
  • Hogg C; Dept of Pediatric Pulmonology, VU University Medical Center, Amsterdam, The Netherlands.
  • Maitre B; Depts of Paediatrics and Paediatric Respiratory Medicine, Imperial College and Royal Brompton Hospital, London, UK.
  • Marsh G; Pulmonary Service, Centre constitutif Respirare, Centre Hospitalier intercommunal de Créteil, Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.
  • Martinu V; Depts of Paediatrics and Paediatric Respiratory Medicine, Imperial College and Royal Brompton Hospital, London, UK.
  • Moreno-Galdó A; Paediatric Pulmonology, Paediatric Dept, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Mussaffi H; Dept of Pediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Omran H; CIBER of Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • Pohunek P; Schneider Children's Medical Center of Israel, Petach-Tikva, Sackler School of Medicine, Tel-Aviv, Israel.
  • Rindlisbacher B; Dept of General Paediatrics and Adolescent Medicine, University Hospital Muenster, Muenster, Germany.
  • Robinson P; Paediatric Pulmonology, Paediatric Dept, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Snijders D; Kartagener Syndrom und Primäre Ciliäre Dyskinesie, Steffisburg, Switzerland.
  • Walker WT; Patient representative.
  • Yiallouros P; Dept of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Australia.
  • Johansen HK; Dept of Paediatrics, University of Melbourne, Parkville, Australia.
  • Nielsen KG; Murdoch Children's Research Institute, Parkville, Australia.
ERJ Open Res ; 7(3)2021 Jul.
Article em En | MEDLINE | ID: mdl-34350277
ABSTRACT

INTRODUCTION:

In primary ciliary dyskinesia (PCD) impaired mucociliary clearance leads to recurrent airway infections and progressive lung destruction, and concern over chronic airway infection and patient-to-patient transmission is considerable. So far, there has been no defined consensus on how to control infection across centres caring for patients with PCD. Within the BEAT-PCD network, COST Action and ERS CRC together with the ERN-Lung PCD core a first initiative has now been taken towards creating such a consensus statement.

METHODS:

A multidisciplinary international PCD expert panel was set up to create a consensus statement for infection prevention and control (IP&C) for PCD, covering diagnostic microbiology, infection prevention for specific pathogens considered indicated for treatment and segregation aspects. Using a modified Delphi process, consensus to a statement demanded at least 80% agreement within the PCD expert panel group. Patient organisation representatives were involved throughout the process.

RESULTS:

We present a consensus statement on 20 IP&C statements for PCD including suggested actions for microbiological identification, indications for treatment of Pseudomonas aeruginosa, Burkholderia cepacia and nontuberculous mycobacteria and suggested segregation aspects aimed to minimise patient-to-patient transmission of infections whether in-hospital, in PCD clinics or wards, or out of hospital at meetings between people with PCD. The statement also includes segregation aspects adapted to the current coronavirus disease 2019 (COVID-19) pandemic.

CONCLUSION:

The first ever international consensus statement on IP&C intended specifically for PCD is presented and is targeted at clinicians managing paediatric and adult patients with PCD, microbiologists, patient organisations and not least the patients and their families.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca